Status:
UNKNOWN
Bioactive Glass or Allogenic Bone in Pediatric Bone Cysts
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
Bonalive Biomaterials Ltd
Conditions:
Bone Cysts
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
The Finnish Paediatric Orthopedic Study Group will perform a prospective, randomized, multicenter, clinical trial comparing two bone substitutes (allograft and bioactive glass, BonAlive®) in treating ...
Detailed Description
Twenty patients will be randomized into each group. In all University Hospitals the treatment protocol will be same. Randomization will be performed using a sealed envelope technique. Before surgery ...
Eligibility Criteria
Inclusion
- Suspected aneurysmatic bone cyst in all areas, not spinal.
- Other large simple bone cyst in load bearing areas
- Simple or aneurysmal bone cyst and a pathological fracture in non load-bearing areas
Exclusion
- Malignancy
- Bone marrow disease
- Other than aneurysmatic or simple bone cyst
- A secondary aneurysmal bone cyst (ABC associated with another underlying lesion)
Key Trial Info
Start Date :
September 5 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04737590
Start Date
September 5 2012
End Date
December 31 2022
Last Update
February 4 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Hospital
Helsinki, Finland
2
Kuopio University Hospital
Kuopio, Finland
3
Oulu University Hospital
Oulu, Finland
4
Tampere University Hospital
Tampere, Finland